KERYX BIOPHARMACEUTICALS INC: key financial figures for fiscal year 2017 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2017)
- $60.6M
- Net Income/Loss (FY2017)
- -$163.4M
- Total Assets (FY2017)
- $158.9M
- Total Equity (FY2017)
- -$14.1M
- Cash Flows from Operating Activities (FY2017)
- -$93.5M
Source: KERYX BIOPHARMACEUTICALS INC 10-K filing (FY2017). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
